MSH6 and glioblastoma: To explore the mechanisms by which AT-888 potentiates TMZ in the context of MSH6 inactivation, we used lentiviral shRNA to knock down MSH6 in BT020, a line derived from a newly diagnosed, MGMT methylated GBM patient.